Stonehage Fleming Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Stonehage Fleming Financial Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,000	Closed	-$465K	–	267
2024 Q1	$465K	Buy	+20,000	New	+$469K	0.03%	75
2023 Q4	–	Sell	-14,000	Closed	-$285K	–	259
2023 Q3	$285K	Buy	+14,000	New	+$314K	0.03%	132
2023 Q2	–	Sell	-20,000	Closed	-$465K	–	222
2023 Q1	$465K	Hold	20,000	–	–	0.03%	75
2022 Q4	$503K	Sell	20,000 -10,000	-33%	-$269K	0.04%	71
2022 Q3	$791K	Hold	30,000	–	–	0.06%	49
2022 Q2	$867K	Buy	30,000 +4,000	+15%	+$119K	0.03%	76
2022 Q1	$895K	Buy	26,000 +4,500	+21%	+$159K	0.03%	83
2021 Q4	$941K	Buy	+21,500	New	+$1.02M	0.03%	87

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stonehage Fleming Financial Services's IDNA Position: Q2 2024 in Review

Stonehage Fleming Financial Services sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2024, closing a stake of 20,000 shares — an estimated $465K sold.

Stonehage Fleming Financial Services first reported a position in IDNA in Q4 2021 and held it in 8 quarters. The position peaked at $941K in Q4 2021. 62 funds tracked by Wall St. Rank hold IDNA as of Q2 2024.

Stonehage Fleming Financial Services reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2024 after selling out during the quarter.
Stonehage Fleming Financial Services sold 20,000 iShares Genomics Immunology and Healthcare ETF shares in Q2 2024, an estimated $465K.
Stonehage Fleming Financial Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and held it in 8 quarters.
Stonehage Fleming Financial Services's iShares Genomics Immunology and Healthcare ETF position peaked at $941K in Q4 2021.
62 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2024.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2024, filed 5 Aug 2024.